参考文献/References:
[1]Sharma N,Koranne RV,Singh RK.Psychiatric morbidity in psoriasis and vitiligo:a comparative study[J].J Dermatol,2001,28(8):419-423.
[2]Nowak A,Breidthardt T,Christ-Crain M,et al.Direct Comparison of Three Natriuretic Peptides for Prediction of Short- and Long-term Mortality in Patients With Community-Acquired Pneumonia[J].Chest,2012,141(4):974-982.
[3]Hodgson D,Nee P,Sultan L.Towards evidence-based emergency medicine:best BETs from the Manchester Royal Infirmary. BET 4:Prognostic value of B-type natriuretic peptides (BNP and NT-proBNP)in community-acquired pneumonia[J].Emerg Med J,2012(29):856-857.
[4]Martolini D,Pistella E,Carmenini E,et al.NT-proBNP correlates with the illness scores pneumonia severity index and CURB-65 in patients with pneumonia[J].Italian Journal of Medicine,2017,11(1):37-40.
[5]中华医学会呼吸病学分会.中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J].中华结核和呼吸杂志,2016,39(4):253-279.
[6]孟爱华,林蕊艳,张虹霞,等.社区获得性肺炎合并与未合并全身炎症反应综合症患者N-末端脑钠肽前体水平变化及临床意义研究[J].中国全科医学,2014,17(2):144-147.
[7]中国医师协会急诊医师分会.中国急诊重症肺炎临床实践专家共识[J].中国急救医学,2016,36(2):97-107.
[8]邓伟吾.社区获得性肺炎诊断治疗进展[J].中华结核和呼吸杂志,2004,27(1):10-12.
[9]Post F,Weilemann LS,Messow CM,et al.B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients[J].Crit Care Med,2008,36(11):3030-3037.
[10]Falcone M,Corrao S,Venditti M,et al.Performance of PSI,CURB-65,and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia[J].Intern Emerg Med,2011,6(5):431-436.
[11]Ogawa T,de Bold AJ.Uncoordinated regulation of atrial natriuretic factor and brain natriuretic peptide in lipopolysaccharide-treated rats[J].Biomarkers,2012,17(2):140-149.
[12]He Q,LaPointe MC.Interleukin-1beta regulation of the human brain natriuretic peptide promoter involves Ras-,Rac-,and p38 kinase-dependent pathways in cardiac myocytes[J].Hypertension,1999,33(1):283-289.
[13]Christ-Crain M,Breidthardt T,Stolz D,et al.Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia[J].J Inter Med,2008,264(2):166-176.
相似文献/References:
[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Medical Information,2018,31(04):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]包克珍,许云丽.新生儿社区获得性肺炎的临床特征分析[J].医学信息,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Medical Information,2018,31(04):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[3]赵建美,邵 岩,李京津.电脑中频药透对治疗老年社区获得性肺炎的疗效分析[J].医学信息,2018,31(03):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
ZHAO Jian-mei,SHAO Yan,LI Jing-jin.Analysis of the Efficacy of Computer Medium Frequency Drug Penetration in the Treatment of Elderly Community-acquired Pneumonia[J].Medical Information,2018,31(04):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
[4]俞 静,赵 红,金 晶,等.社区获得性肺炎胸部CT中反晕征的初步研究[J].医学信息,2022,35(10):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
YU Jing,ZHAO Hong,JIN Jing,et al.Preliminary Study of Reversed Halo Sign in Chest CT of Community-acquired Pneumonia[J].Medical Information,2022,35(04):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
[5]武珊珊.喜炎平注射液治疗社区获得性肺炎临床疗效的Meta分析[J].医学信息,2018,31(14):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
WU Shan-shan.Meta-analysis of Clinical Efficacy of Xiyanping Injection in the Treatment of
Community-acquired Pneumonia[J].Medical Information,2018,31(04):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
[6]徐安林,刘 忠.不同配比的哌拉西林-他唑巴坦治疗
老年性社区获得性肺炎的疗效对比[J].医学信息,2018,31(15):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
XU An-lin,LIU Zhong.Comparison of the Efficacy of Different Ratios of Piperacillin-tazobactam in Elderly Community Acquired Pneumoni[J].Medical Information,2018,31(04):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
[7]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Medical Information,2018,31(04):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[8]远 颖.成人社区获得性肺炎中医药研究[J].医学信息,2018,31(23):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
YUAN Ying.Traditional Chinese Medicine Research on Adult Community Acquired Pneumonia[J].Medical Information,2018,31(04):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
[9]陈亚南,陈 赛,毛琦善.青壮年与中老年社区获得性肺炎病原体的对比分析[J].医学信息,2019,32(01):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
CHEN Ya-nan,CHEN Sai,MAO Qi-shan.Comparative Analysis of Pathogens of Acquired Pneumonia among Young Adults and Middle-aged and Elderly People[J].Medical Information,2019,32(04):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
[10]纪东华.托伐普坦治疗AMI合并心力衰竭的疗效及对患者血清hs-CRP、NT-proBNP表达的影响[J].医学信息,2019,32(16):127.[doi:10.3969/j.issn.1006-1959.2019.16.041]
JI Dong-hua.Efficacy of Tolvaptan in the Treatment of AMI Complicated with Heart Failure and its Effect on
Serum hs-CRP and NT-proBNP Expression[J].Medical Information,2019,32(04):127.[doi:10.3969/j.issn.1006-1959.2019.16.041]